Siegel S R, Weitzman R E, Fisher D A
J Clin Invest. 1979 Feb;63(2):287-93. doi: 10.1172/JCI109301.
The effect of furosemide on plasma renin, vasopressin (AVP), and aldosterone concentrations was studied in 10 control and 6 nephrectomized lambs during the 1st 2 wk of life. In a separate study in 10 newborn lambs, 1-sarcosine-8-alanine-angiotensin II (saralasin acetate, 5 mug/kg per min) was infused alone for 40 min, after which furosemide 2 mg/kg i.v. was injected in association with continuing saralasin acetate infusion. Plasma renin activity increased from a mean (+/-SEM) of 21.3+/-3.4 ng/ml per h in the 10 control lambs to 39.4+/-8.2 ng/ml per h at 8 min (P < 0.001) and remained high through 120 min after furosemide. Plasma AVP and aldosterone concentrations increased from respective mean values of 2.1+/-0.4 muU/ml and 12.8+/-2.5 ng/dl to 9.8+/-2.0 muU/ml (P < 0.01) and 23.0+/-7.7 ng/dl (P < 0.05) at 35 min and 13.8+/-2.1 muU/ml and 23.0+/-4.4 ng/dl at 65 min after furosemide (each P < 0.01). There was an insignificant AVP response in the 10 lambs treated with angiotensin inhibitor: from a mean base line of 4.7+/-0.9 to 8.3+/-2.0 muU/ml at 35 min, and 7.4+/-2.0 muU/ml at 65 min after furosemide. There was no increase in AVP in the anephric lambs. The mean increment AVP response from base line in the newborn lambs without saralasin, Delta 10.8+/-2.0 muU/ml, was greater than in the lambs with saralasin, Delta4.0+/-1.9 (P < 0.05), and greater than in the anephric lambs, Delta3.3+/-2.1 muU/ml (P < 0.05). The mean blood pressure fell 6 mm Hg in the 10 control lambs (P < 0.05), 7 mm Hg in the anephric lambs (P < 0.05), and 16 mm Hg in the lambs treated with angiotensin inhibitor (P < 0.05) by 35 min after furosemide. However, the changes in plasma AVP were not related to the fall in blood pressure. These data support the view that the observed AVP response to furosemide in the newborn lamb was mediated through the renin-angiotensin system.
在10只对照羔羊和6只肾切除羔羊出生后的前2周内,研究了呋塞米对血浆肾素、血管加压素(AVP)和醛固酮浓度的影响。在另一项针对10只新生羔羊的研究中,单独输注1-肌氨酸-8-丙氨酸-血管紧张素II(醋酸沙拉新,5微克/千克每分钟)40分钟,之后静脉注射2毫克/千克呋塞米并继续输注醋酸沙拉新。10只对照羔羊的血浆肾素活性从平均(±标准误)每小时21.3±3.4纳克/毫升增加到呋塞米注射后8分钟时的39.4±8.2纳克/毫升(P<0.001),并在呋塞米注射后120分钟内一直保持在较高水平。血浆AVP和醛固酮浓度分别从各自的平均值每毫升2.1±0.4微单位和每分升12.8±2.5纳克增加到呋塞米注射后35分钟时的每毫升9.8±2.0微单位(P<0.01)和每分升23.0±7.7纳克(P<0.05),以及65分钟时的每毫升13.8±2.1微单位和每分升23.0±4.4纳克(各P<0.01)。在接受血管紧张素抑制剂治疗的10只羔羊中,AVP反应不显著:从平均基线水平每毫升4.7±0.9微单位增加到呋塞米注射后35分钟时的每毫升8.3±2.0微单位,以及65分钟时的每毫升7.4±2.0微单位。无肾羔羊的AVP没有增加。未使用沙拉新的新生羔羊AVP反应从基线的平均增量为每毫升10.8±2.0微单位,大于使用沙拉新的羔羊的增量每毫升4.0±1.9微单位(P<0.05),且大于无肾羔羊的增量每毫升3.3±2.1微单位(P<0.05)。在呋塞米注射后35分钟时,10只对照羔羊的平均血压下降了6毫米汞柱(P<0.05),无肾羔羊下降了7毫米汞柱(P<0.05),接受血管紧张素抑制剂治疗的羔羊下降了16毫米汞柱(P<0.05)。然而,血浆AVP的变化与血压下降无关。这些数据支持这样一种观点,即新生羔羊中观察到的对呋塞米的AVP反应是通过肾素-血管紧张素系统介导的。